Poolbeg Pharma wins first non-dilutive grant funding | News Direct

Poolbeg Pharma wins first non-dilutive grant funding

Poolbeg Pharma PLC
Digital Asset Direct by Poolbeg Pharma PLC
Download PDF Download multimedia

facebook icon linkedin icon twitter icon pinterest icon email icon London, UK | November 21, 2022 06:35 AM Eastern Standard Time

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington dials in from the Jefferies London Healthcare Conference to tell Proactive that a consortium led by Poolbeg has been awarded €2.3m in non-dilutive grant funding from the Irish government. The money will be used to support the development of an oral vaccine platform that will make it easier to "generate numerous oral vaccines" in the future.

 

Contact Details

 

Proactive

 

Proactive UK Ltd

 

+44 20 7989 0813

 

uk@proactiveinvestors.com

News Direct Logo
Follow us on Facebook Follow us on LinkedIn
Get the latest from News Direct
Contact Us Pricing
Why News Direct
About us Features News Hub
Resources
Terms of Use Privacy Policy
newsdirect.com © 2025 News Direct Corp. All rights reserved. News Direct is a registered trademark.